↓ Skip to main content

Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer

Overview of attention for article published in Frontiers in oncology, July 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#26 of 22,758)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
33 news outlets
twitter
1 X user

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer
Published in
Frontiers in oncology, July 2021
DOI 10.3389/fonc.2021.617874
Pubmed ID
Authors

Nuhad K Ibrahim

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 12%
Student > Master 3 9%
Student > Doctoral Student 2 6%
Student > Postgraduate 2 6%
Student > Bachelor 1 3%
Other 3 9%
Unknown 18 55%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 12%
Medicine and Dentistry 4 12%
Agricultural and Biological Sciences 2 6%
Unspecified 1 3%
Chemistry 1 3%
Other 2 6%
Unknown 19 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 244. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2023.
All research outputs
#155,383
of 25,655,374 outputs
Outputs from Frontiers in oncology
#26
of 22,758 outputs
Outputs of similar age
#4,525
of 451,849 outputs
Outputs of similar age from Frontiers in oncology
#3
of 1,395 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,849 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 1,395 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.